Author
Hiroya Takeuchi
Recent research
- Health & Medicine
Programmed death-ligand 1 (PD-L1) plays a central role in immune regulation in esophageal squamous cell carcinoma (ESCC) and has been widely used as a biomarker for immune checkpoint inhibitor therapy. However, the biological and clinical significance of PD-L1 expression remains...